secwatch.observer — SEC 8-K summary
======================================

Issuer:     Actinium Pharmaceuticals, Inc. (ATNM)
CIK:        0001388320
Form:       8-K
Filed at:   2025-05-09T23:59:59+00:00
Accession:  0001213900-25-041582
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Actinium dismisses Marcum, engages CBIZ CPAs as auditor after Marcum acquisition
--------------------------------------------------------------------------------

- Marcum LLP dismissed as independent auditor on May 8, 2025, due to CBIZ CPAs acquiring its attest business.
- CBIZ CPAs engaged as new auditor for fiscal year ending Dec 31, 2025, effective May 8, 2025.
- No disagreements or reportable events occurred with Marcum during fiscal years 2024, 2023, and through May 8, 2025.
- Marcum's audit reports for 2024 and 2023 were unqualified; Marcum provided a letter agreeing with the company's disclosures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388320/000121390025041582/0001213900-25-041582-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388320/000121390025041582/ea0241600-8k_actinium.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-041582

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer